# Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21

> **NCT01387776** · — · TERMINATED · sponsor: **Clinique Ovo** · enrollment: 370 (actual)

## Conditions studied

- Pregnancy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01387776
- **Lead sponsor:** Clinique Ovo
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 370 (ACTUAL)
- **Why stopped:** The technique has been approved and validated
- **Last updated:** 2015-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01387776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01387776, "Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01387776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*